Internal hemipelvectomy and reconstruction with a megaprosthesis.
We treated nine consecutive patients by internal hemipelvectomy and reconstruction with custom-made megaprosthesis between 1990 and 1997. Four had a primary malignant bone or soft tissue tumour, one a recurrent benign giant cell tumour, three solitary metastatic bony lesions, and one a pelvic defect secondary to multiple revision procedures after total hip replacement. After a mean follow-up period of 62 (40-102) months five patients were still alive, including four of the eight patients with tumours. Three patients died as a result of the malignant disease, and one died of an infection related to the surgical treatment after 10-41 months. In two patients removal of the prosthesis was required due to infection, and six patients suffered various complications. One patient had an excellent outcome.
Müller
P E
PE
Department of Orthopedics, Universität Rostock, Germany. peter.mueller@med.uni-rostock.de
Dürr
H R
HR
Wegener
B
B
Pellengahr
C
C
Refior
H J
HJ
Jansson
V
V
D000293:Adolescent; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000601:surgery*; D005260:Female; D006428:Hemipelvectomy / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010384:Pelvic Bones / Q000601:surgery*; D011183:Postoperative Complications; D019736:Prostheses and Implants; D016019:Survival Analysis; D016896:Treatment Outcome